Charlie is a Neurology Specialist in the Department of Medicine and Therapeutics at Prince of Wales Hospital, and a Clinical Assistant Professor (Honorary) at The Chinese University of Hong Kong. His clinical and academic work focuses on epilepsy and neurological disorders.

Charlie’s professional involvement includes serving as a Council Member of the Hong Kong Epilepsy Society and a Youth Committee Member of the Chinese Association Against Epilepsy. He and the Epilepsy Management Team have received notable recognition, including the Accreditation of a Comprehensive Epilepsy Centre by the China Association Against Epilepsy (2025) and the Outstanding Team Award (New Territories East Cluster) in Functional Neuroscience by the Hospital Authority (2024), for improving quality and efficiency of the clinical services in Hong Kong.

Cheuk Kui is a highly experienced nursing professional currently serving as a Nurse Consultant in the Department of Neurosurgery at Tuen Mun Hospital under the Hospital Authority in Hong Kong. He obtained his Bachelor’s degree in Nursing from Monash University (1998). He began his career as a Registered Nurse from 1997 to 2008, advanced to Advanced Practice Nurse from 2008 to 2014, and later served as Ward Manager from 2014 to 2020. Since 2021, he has been appointed as a Nurse Consultant. Throughout his career, Cheuk Kui has been dedicated to advancing neurosurgical nursing services, with a long-standing commitment to enhancing the quality and safety of patient care.

Danny is the Head of Division of Neurosurgery and a Clinical Associate Professor (Honorary) in the Department of Surgery at The Chinese University of Hong Kong (CUHK). He also serves as the Co-Director of CUHK Otto Lien Da Wong Brain Tumour Centre. In addition, he is the Chief of Department of Neurosurgery of Prince of Wales Hospital and the Chairman of Coordinating Committee for Neurosurgery of Hong Kong Hospital Authority, leading the neurosurgical services across Hong Kong.

Danny’s research interests include neuro-oncology (particularly glioblastoma) and functional neurosurgery (Parkinson’s disease and epilepsy). His multi-disciplinary work in these areas has been recognised locally and internationally, contributing to the establishment of the CUHK Otto Wong Brain Tumour Centre, the Mr Otto Lien Da Wong Visiting Professorship in Neuro-oncology, the Combined Neuro-oncology Clinic, the Combined Movement Disorder Clinic and the Deep Brain Stimulation programme.

In recent years, Dr Chan’s collaborative research has been expanded to medical engineering on stereotactic neuro-robots, novel cellular imaging techniques and Al-driven precision therapeutics. His team received the Best Paper Award in Medical Robotics and the best Conference paper at the IEEE international conference on Robotics and Automation (lCRA) 2018, as well as a Bronze Medal at the 2022 Special Edition of the Geneva International Exhibition of Inventions. More recently, Danny was awarded the 2022 Bank of China (Hong Kong) Science and Technology Innovation Prize (Artificial Intelligence and Robotics) for a collaborative project on a flexible robotised neuro-endoscopy system developed with Professor Hongbin Liu of CAIR.

Dr Chang is the Joan and Sanford I. Weill Chair and Professor of Neurological Surgery at UCSF, where he also serves as the Chairman. He is a clinician-scientist practising neurosurgery specialising in the treatment of intractable epilepsy, brain tumours, and cranial nerve compression syndromes. He is a global leader in awake intraoperative brain mapping, using advanced stimulation and recording methods to preserve critical speech and motor functions during surgery. He also has extensive experience with implantable neuromodulation devices for seizure, movement, pain and other neurological disorders.

Dr Chang's research focuses on the brain mechanisms underlying speech, movement and human emotion. He co‑directs the Center for Neural Engineering and Prostheses, a collaborative enterprise between UCSF and the University of California, Berkeley. He leads an interdisciplinary research program investigating the neural mechanisms of human speech perception and production, movement, and emotion. His team is internationally recognised for high resolution intracranial recordings that have revealed the functional architecture of human speech cortex and enabled real time speech neuroprostheses—including brain to text, synthesised voice, and avatar-based communication for people with paralysis.

Dr Chang received his Bachelor’s degree in Chemistry from Amherst College and his medical degree from UCSF, where he also completed residency training in neurological surgery. He subsequently completed a postdoctoral fellowship in cognitive neuroscience at UC Berkeley before joining the UCSF faculty in 2010. He was appointed department chair in 2020.

Dr Chang’s honours include the Blavatnik National Laureate for Life Sciences in 2015 in recognition of his contributions to deciphering the neural code of speech, the inaugural Bowes Biomedical Investigator at UCSF and HHMI Faculty Scholar, election to the National Academy of Medicine in 2020 and the National Academy of Sciences in 2025. Most recently, he was awarded the 2025 Gruber Neuroscience Prize, one of the world’s most prestigious international honours in neuroscience. The award citation highlights Dr. Chang’s pioneering integration of high‑resolution cortical recordings and stimulation in awake humans, which reshaped modern neuroscience by revealing how the brain encodes speech sounds, rhythms, and articulatory movements—and by enabling the development of the first successful speech neuroprostheses to restore communication in people with paralysis.

Professor Gui was a medical graduate of Southeast University in Nanjing. China (1994) and obtained his PhD degree from Beijing Capital Medical University (2007). He further pursued training in endoscopic surgery in Minimally Invasive Skull Base Surgery Center, University of Pittsburgh Medical Center (2011). Professor Gui joined the Department of Neurosurgery of Beijing Tiantan Hospital in 2007. He is now a Professor and Head of Neuro-oncology Division III of the Department.

Professor Gui has extensive experience in the diagnosis, and microscopic and endoscopic surgical treatment of brain tumours and diseases of cisterns, especially in endoscopic skull base surgery in pituitary tumours, craniopharyngiomas, chordomas, tuberculum sellae meningiomas. His research interests are endoscopic neurosurgery, and basic and clinical research in craniopharyngiomas.

Professor Gui holds several committee positions in The Chinese Medical Doctor Association, Vice Chairman of the Neuro-endoscopy Committee of Neurosurgery Division, Deputy Director General and Standing Committee Member for the Endoscopy Division, and Vice President and Dean of the Neuro-endoscopy Training Institute. He is an Editorial Board Member of the Chinese Journal of Minimally Invasive Surgery, Journal of Neuroscience and Mental Health, and Journal of Chinese Practical Diagnosis and Therapy. He is also a regular Reviewer of the Chinese Journal of Neurosurgery and Neurosurgical Review.

Aya is a clinician scientist specializing in early-phase clinical trials, drug development, biomarkers, and genomics, with a particular focus on neuro-oncology. She joined the Department of Clinical Oncology at the University of Hong Kong, where she also serves as co-chair of the HKU-Hong Kong Sanatorium & Hospital Molecular Tumor Board. Additionally, she is the First Vice President and Past President of the Hong Kong Neuro-Oncology Society.

Aya is a medical graduate of National University of Ireland, Galway, graduating with honours and gold medals in Medicine and Surgery. She acquired a PhD from Queen's University Belfast as a recipient of the prestigious Sir Allen McClay Clinical Research Fellowship. Her doctoral research centred on biomarker discovery and drug development, while her postdoctoral fellowship advanced novel therapeutic strategies to enhance the adaptive immune system through innovative drug combinations. Her translational research investigates the mechanisms of resistance to immune checkpoint inhibitors, with a focus on immune escape, epigenetics, and metabolomics in glioblastoma.

Professor Jiang is a member (Academician) of the Chinese Academy of Engineering. He currently serves as the Chairman of Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Director of the Beijing Neurosurgical Institute, and Vice President of the School of Neurosurgery at the Capital Medical University. Professor Jiang is a strong advocate of awake surgery for glioma of the functional region, doing his best to minimise and prospectively document operative complications. He also pioneered individualised comprehensive treatment of gliomas guided by molecular pathology in China.

Professor Jiang is a leading expert in clinical and scientific research in gliomas. He is the Principal Investigator for serval key projects supported by the Ministry of Science and Technology, including the National High-tech R&D Program (863 Program). He established the first clinical sample library for gliomas, and pioneered genomic research on gliomas in China. He introduced the molecular typing into glioma classification before the update in 2021 WHO classification. Professor Jiang is the Founder and Chairman of the Chinese Glioma Genome Atlas (CGGA), which is the largest glioma multi-omics database covering whole genome/ transcriptome/ epigenetic data from more than 2,500 patients. His team discovered the key driver "PTPRZ1-MET" fusion gene in the progression of glioma malignancy. The team also developed a small-molecule MET inhibitor “PLB-1001”, and completed phase I to III clinical trials. The publication in Cell was recognized as one of the Top Ten Advances in Life Sciences in China in 2018. The drug has been approved recently for the glioma indications.

Professor Jiang has published more than 360 papers as a corresponding author in high-impact journals such as Cell and PNAS. He has an H-index of 78 and his publications have been cited 21774 times. 23 papers are in the top 1% of the most cited papers, 46 papers are included in national and international guidelines, and 20 are cited in international policy documents.

William is a Specialist in Neurology at Queen Mary Hospital. He previously served as a Research Fellow in Neurology at Massachusetts General Hospital and Harvard Medical School (2024–2025). He completed his medicine degree at The University of Hong Kong.

His research focuses on post stroke epilepsy risk prediction, modifiable determinants of brain health, and the gut–brain axis in epilepsy. He has published extensively in journals such as Vaccines, Stroke, Epilepsy & Behavior, and the Cochrane Database of Systematic Reviews. He also serves on the Board of Directors of the Epilepsy Foundation of Hong Kong and as a Council Member of the Hong Kong Neuroimmunology Society.

His recent honours include the Li Ka Shing Medical Fellowship (2025) and the Distinguished Young Fellow of the Hong Kong Academy of Medicine (2024).

Professor Lim is a Professor of Neurology at the University of Malaya and Head of the Neurology Unit at the University of Malaya Medical Centre (UMMC). He graduated in Medicine from University of Malaya in 1999, completed neurology subspeciality training in 2008, and pursued advanced epilepsy fellowships in Melbourne (2011) and Cleveland (2017).

Professor Lim holds significant leadership roles regionally and internationally. He is currently the President of the ASEAN Neurological Association (ASNA) and Chair elect (2025–2029) of the Asian and Oceanian Commission of the International League Against Epilepsy (ILAE AO).

His clinical expertise spans comprehensive non-invasive and invasive epilepsy evaluation. His research covers psychosocial aspects of epilepsy, epilepsy surgery, tumour related seizures, genetics of focal and familial epilepsies, pharmacogenomics, pharmacokinetics of antiepileptic drugs, quantitative EEG and MRI, and applications of artificial intelligence.

He also serves as Associate Editor of Neurology Asia, a reviewer for multiple academic journals, and an organising committee member for both national and international scientific meetings. He has supervised 20 postgraduate students and 30 international neurology fellows, contributing extensively to capacity building in neurology across the region.

Yicong completed her medical education at Peking Union Medical College before joining Xuanwu Hospital as a resident in 2008. She later undertook a research fellowship at the Cleveland Clinic. Yicong is currently an Associate Professor in the Department of Neurology at Xuanwu Hospital, Capital Medical University, specialising in epilepsy and neuromodulation. She also serves as Deputy Director of the Office of the National Center for Neurological Disorders.

Yicong plays an active role in serval national professional organisations. She is Vice‑Chair of the Youth Committee of the Beijing Anti‑Epilepsy Association, a member of the EEG and Epilepsy Subgroup of the Chinese Society of Neurology, Deputy Secretary‑General of the China Association Against Epilepsy (CAAE), and a Youth Committee Member of the Neuromodulation branch of the Chinese Medical Doctor Association.

Her research interests include epileptic focus localization, magnetoencephalography, MRI‑negative epilepsy, neuromodulation (rTMS, tDCS), epilepsy epidemiology, and neuroimaging post‑processing. Her work continues to integrate clinical experise with research innovation in epilepsy and neuromodulation.

Ms Liu is the Head Nurse of the Operating Room at Beijing Tiantan Hospital, Capital Medical University, and a Deputy Chief Nurse with extensive experience in perioperative and neurosurgical nursing. She is also a certified Nursing Management Specialist of the Beijing Nursing Association.

Ms Liu holds multiple academic and professional appointments, including Committee Member of the Operating Room Specialty Committee of the Chinese Nursing Association, Committee Member of the Operating Room Specialty Committee of the Beijing Nursing Association, and Board Member of the Nursing Branch of the Chinese Research Hospital Association.

Her research focuses on neurosurgical perioperative nursing and nursing management, contributing to improvements in surgical safety, workflow optimization, and evidence based clinical practice.

Dr Luo is the Director of the Chinese Institute for Brain Research, Beijing, and a New Cornerstone Investigator. He earned a Bachelor’s degree in Psychology from Peking University (1995), followed by an Master’s degree in Computer Science and a PhD in Neuroscience from the University of Pennsylvania (1997, 2000). After completing postdoctoral training at the Howard Hughes Medical Institute and Duke University, he returned to China in 2004, where he served as an Investigator at the National Institute of Biological Sciences, Beijing, and as a Professor at Tsinghua University.

Dr Luo’s research focuses on the neural circuits that govern reward-related behaviours and how their dysfunction contributes to mental disorders. In addition to basic neuroscience, his work aims to develop novel experimental methods, gene-based therapies, and advanced brain-machine interface technologies.

Wendy received her Bachelor's and Master's degrees in Electrical Engineering from the University of Science and Technology of China (USTC). She later earned her PhD in Electrical Engineering from the University of Florida, USA. From 2010 to 2016, she served as an Associate Professor at Zhejiang University. She is currently an Associate Professor (substantiated) in both the Department of Electronic and Computer Engineering and the Department of Chemical and Biological Engineering at the Hong Kong University of Science and Technology.

Her research interests span neural decoding in brain-machine interfaces, adaptive signal processing, computational neuroscience, and neuromorphic engineering. She has made significant contributions to neural engineering through advanced decoding algorithms, reinforcement-learning-based brain-machine interface methods and models of neural adaptation. Wendy has held a number of leadership and editorial roles, including Associate Editor of IEEE Transactions on Cognitive and Developmental Engineering, Editorial Board Member of Journal of Neural Engineering, and Associate Editor of Brain-Computer Interfaces (Frontiers in Human Neuroscience).

Professor Wang is the Chair of the Department of Neurology at Xuanwu Hospital, Capital Medical University. He is one of China's leading neurologist and neuroscientist, with clinical and research expertise spanning epilepsy, movement disorders, sleep medicine, psychosomatic diseases, and neuromodulation therapies. He found the Beijing Epilepsy Diagnosis and Treatment Centre, one of the earliest and largest specialised epilepsy centres in China, and the first to identify the cognitive-related ERP component N270, an electrophysiological marker of conflict processing and cognition–consciousness transformation.

Professor Wang has led the development of multiple innovative neuromodulation technologies, including multi-target transcranial electrical-magnetic stimulation systems and wearable brain signal regulation devices, and has developed novel therapeutic protocols for brain function disorders. He has directed numerous national research programmes under major funding schemes, and has received serval top national honours, including the Chinese Medical Award, the Beijing Science and Technology Progress Award, and the Wu Jieping Medical Award.

Professor Wang also serves in key international and national roles, including Member of the Clinical Practice Guideline Working Group of the International League Against Epilepsy (ILAE), Member of the Education Committee of the World Sleep Society, Chair of the Neurology Branch of the China International Exchange and Promotive Association for Medical and Health Care, and Vice President of the China Association Against Epilepsy (CAAE).

Hemmings is currently an Attending Neurosurgeon and a Research Professor at the Department of Neurosurgery at Zhejiang University Second Affiliated Hospital in Hangzhou. He received his medical degree from Peking University, completed his Master’s degree and neurosurgery residency at Shanghai Jiaotong University, and later pursued his PhD in Neuroscience at KU Leuven. He subsequently completed postdoctoral training at Stanford University.

His long-term career vision lies at the intersection of clinical neurosurgery, basic neuroscience, and translational neurotechnology. He is a fully trained functional neurosurgeon specializing in deep brain stimulation and other neuromodulation techniques for a wide range of neurological disorders, including Parkinson’s disease, dystonia, epilepsy, pain, and psychiatric disorders. His research interests focuses on neurophysiological mechanisms underlying neuropsychiatric disorders, and translational strategies to improve next-generation neuromodulation therapies.

Yuxiao is an Assistant Professor at the MOE Frontier Science Center for Brain Science and Brain-machine Integration and the State Key Laboratory of Brain-machine Intelligence, Zhejiang University. Before joining Zhejiang University, he served as an Assistant Professor of Electrical and Computer Engineering at the University of Central Florida (UCF).

He received his Bachelor’s degree in Electronics Engineering from Tsinghua University in 2013 and a PhD degree in Electrical and Computer Engineering from University of Southern California in 2019. His research focuses on designing closed-loop brain-machine interface (BMI) systems for neural decoding and control, with the goal of developing new therapeutic strategies for neurological and neuropsychiatric disorders. Yuxiao has published in leading neural engineering journals, with high-impact papers in Nature Biotechnology and Nature Biomedical Engineering. His achievements have been recognised through multiple major awards, including the IEEE EMBS Best Student Paper Award (2015), and the Annual Brain-Computer Interface Award (2019). He also received the China BMI Rising Star Award (2025).

Leo is an Associate Consultant in the Department of Neurosurgery at Prince of Wales Hospital, and a Clinical Assistant Professor (Honorary) at The Chinese University of Hong Kong (CUHK). With over 10 years of frontline experience in the public healthcare sector, he has developed subspecialty expertise in neuroendoscopy and minimally invasive neurosurgery for skull base tumours. He plays a key role in the Combined Pituitary Clinic, a one stop multidisciplinary service integrating neurosurgery and endocrinology. He has contributed significantly to service enhancement, including the establishment of a pituitary tumour registry and the advancement of precision transsphenoidal surgery through close collaboration with ENT surgeons and anaesthetists.

Leo is also actively engaged in neurosurgical education and training, serving as speaker, trainer and organiser in skull base, neuro-endoscopy, and micro-neurosurgical courses and workshops. His clinical practice combines advanced minimally invasive techniques with a strong commitment to multidisciplinary care, service innovation, and neurosurgical education.

Stephen is a staff neuropathologist at Vancouver General Hospital and Medical Director of Clinical Cancer Genomics at BC Cancer, where he overseas all cancer-related germline and somatic molecular testing for the province of British Columbia.

He completed his combined MD-PhD training at the University of Bristish Columbia (UBC), followed by 4 years of neurosurgical residency training at UBC. He later transitioned to neuropathology, obtained Royal College certification and pursued fellowship training at Massachusetts General Hospital (MGH), as well as molecular genetic pathology training at MGH/Harvard Medical School. Stephen’s clinical and research interests focus on the molecular pathogenesis of primary brain tumours and the deployment of novel molecular diagnostic tools to advance precision cancer care.

Yihan received his Bachelor's degree in Microelectronics from Tsinghua University in 2013, his Master’s degree in Mechanical Engineering from Columbia University in 2014, and his PhD degree in Electrical Engineering from Columbia University in 2020. He worked as a postdoctoral fellow in Peking University before joining The Hong Kong University of Science and Technology (HKUST) as an Assistant Professor in 2023.

His research group focuses on exploring analogy and mixed-signal integrated circuit design in the nW/sub nW power regime, as well as ultra-low power integrated-circuit-based systems that realize novel applications. His work has been published in leading venues, including top-tier circuit conferences such as IEEE International Solid-State Circuits Conference (ISSCC), the IEEE Symposium on VLSI Circuits (VLSI-C), and the IEEE Custom Integrated Circuits Conference (CICC), as well as journals such as Nature Communications, The Proceedings of the National Academy of Sciences (PNAS), IEEE Journal of Solid-State Circuits (JSSC), and IEEE Transactions of Circuits and Systems-I (TCAS-I).

Professor Zhao is an Academician of the Chinese Academy of Sciences, a leading neurosurgeon, and highly influential figure in fields of cerebrovascular and tumour neurosurgery in China. He currently serves as Professor in the Department of Neurosurgery and Director of the Brain-Computer Interface Translational Research Center at Beijing Tiantan Hospital, Capital Medical University. He is also Director of the China National Clinical Research Center for Neurological Diseases and the Vice Director of the Chinese Institute for Brain Research, Beijing.

Professor Zhao has devoted his career to clinical and research advancement of neurosurgery. His areas of expertise include brain tumours, cerebrovascular diseases, head trauma, minimally invasive neurosurgery. Over the course of his career, Professor Zhao has led major national neurosurgical efforts and contributed extensively to improving diagnostic and surgical techniques in areas such as moyamoya disease and cerebrovascular neurosurgery, as reflected in his publications and leadership roles.

In recent years, Professor Zhao has participated in the development and clinical translation of brain-computer interface (BCI) technologies, particularly through Beijing Tiantan Hospital’s involvement in China's early BCI clinical ward initiative. His work contributes the emerging national effort to integrate BCI technologies into neurosurgical care and neurological rehabilitation.